Abbott stock surged after Q2 earnings beat expectations and management raised full-year EPS guidance.
read the report →← every name covered
S&P 500
ABT
Abbott Laboratories
latest move
+12.66%
2026-07-22
4 sessions · 2026-07-16 → 2026-07-22 · avg 11.84% · largest 12.84%
Abbott Laboratories is a diversified global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of products across four primary segments: Medical Devices, Diagnostics, Nutritional Products, and Established Pharmaceuticals.
Price history
stitched from the price window carried by each report
Every session it moved
newest first2026-07-22Bullish
+12.66%weekly change2026-07-21Bullish
+12.84%weekly changeAbbott stock surged after Q2 2026 earnings beat estimates and management raised full-year EPS guidance.
read the report →2026-07-20Bullish
+11.16%weekly changeAbbott beat Q2 earnings estimates, raised full-year profit guidance, and the DOJ closed its criminal infant formula investigation.
read the report →2026-07-16Bullish
+10.71%24 hours changeAbbott surged following strong Q2 2026 earnings and revenue beats, raised full-year guidance, and solid growth in Medical Devices.
read the report →